Residency · Englewood, NJ
Sponsored by Rutgers Health
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.
The New England journal of medicine · 2021 · 759 citations · Shobha Swaminathan
Acquired Resistance to KRASG12C Inhibition in Cancer.
The New England journal of medicine · 2021 · 1,038 citations · Viola Zhu
Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
JAMA · 2021 · 739 citations · Princy Kumar
H5N1 highly pathogenic avian influenza clade 2.3.4.4b in wild and domestic birds: Introductions into the United States and reassortments, December 2021-April 2022.
Virology · 2023 · 189 citations · Anna Leyson
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
The New England journal of medicine · 2021 · 533 citations · Princy Kumar
Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study.
The Lancet. Oncology · 2021 · 362 citations · Viola Zhu
Structural Heart Imaging Using 3-Dimensional Intracardiac Echocardiography: JACC: Cardiovascular Imaging Position Statement.
JACC. Cardiovascular imaging · 2025 · 51 citations · Parasuram Krishnamoorthy
Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study.
The lancet. Diabetes & endocrinology · 2021 · 302 citations · Viola Zhu